ZBH

Zimmer Biomet Holdings, Inc. (ZBH)

Monday, October 19, 2026
Past 1Y
MA21MA180
Signals
BuyEarly buySellEarly sellTurning points
Swing highSwing low
Up dayDown day

Zimmer Biomet (ZBH) at a glance

Close · Oct 19, 2026
$95.01
Day change
+0.03%
52-week range
$79.12 – $106.31
Market cap
$18.1B
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE

Zimmer Biomet stock: what the data says

Zimmer Biomet (ZBH) closed at $95.01 on Oct 19, 2026, up 0.0% on the day. The stock is down 0.4% over the past month, up 6.8% over three months, up 5.9% year to date and down 4.4% over the past year. It trades 10.6% below its 52-week high of $106.31 and 20.1% above its 52-week low of $79.12. The close sits below its 50-day moving average ($95.25) and above its 200-day moving average ($91.34).

NextPick tracks ZBH in its Medical Devices basket alongside ABT, ISRG, MDT, SYK and BSX. As of Oct 19, 2026, the basket's money-flow score is 4 (neutral), and the basket is up 2.2% over five sessions. Over the past month ZBH ranks 11th of 13 basket members by price change.

ZBH stock: key questions

Is ZBH above its 200-day moving average?

Yes — the Oct 19, 2026 close of $95.01 is 4.0% above the 200-day average of $91.34.

How far is ZBH from its 52-week high?

ZBH closed 10.6% below its 52-week high of $106.31.

What stocks are similar to ZBH?

NextPick groups ZBH with ABT, ISRG, MDT, SYK and BSX in its Medical Devices basket.

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

zimmerbiomet.com